Navigation Links
Abattis Signs LOI With Crudessence Kombucha Inc. To License Infused, Blended Kombucha Tea
Date:3/6/2013

VANCOUVER, British Columbia, March 6, 2013 /PRNewswire/ -- Abattis Bioceuticals Corp. (the "Company" or "Abattis") (OTC PINK: ATTBF) (CNSX: FLU), announces it has signed a letter of intent with Crudessence Kombucha Inc. ("RISE") to acquire the worldwide exclusive license "the License" to produce, distribute, market and sell a Kombucha tea infused or blended with additional nutraceutical and bioceutical formulas developed and owned by Abattis and its subsidiaries. Under the Terms of the Agreement will acquire "the License" in exchange for 500,000 shares of Abattis at a deemed price of CAD $0.20 and a running technology royalty fee to "RISE".

Rise Kombucha is a highly successful brand sold across Canada, the purpose of the LOI is to enable Abattis to initially bring a new brand of Cannabidiol CBD infused probiotic functional beverages to the markets starting in Washington and Colorado, the brand will be launched as "Cannabucha Sun Rise™" this product will be the first of its kind with infused Cannabidiol "CBD" with the probiotic effects to create one of the best possible health drinks in the world. Kombucha is a microbial culture of various bacteria and yeast species. Fermentation of the culture in naturally sweetened tea produces numerous organic acids such as ascetic acid, gluconic acid, malic acid, amino acids and enzymes, and polyphenols (e.g. catechins) that improve overall health.

Mr. Mike Withrow , Chief Executive Officer on behalf of the Company, stated, "We are very excited to enter into the emerging US CBD infused product markets, leading with a Kombucha beverage which is fast growing in popularity. Kombucha is a perfect delivery beverage for CBD's because it is a functional probiotic drink that strengthens the immune system, balances intestinal flora, stimulates digestion, combats stress, and increases energy."  Mr. Withrow went on to say, "With Mr. Tim Fealey , former Executive VP of Product Development for The Coca Cola Company and as our VP of Product Development we are able to ensure we achieve all of the necessary goals to make this a huge success in the markets we address."

About Abattis Bioceuticals Corp.

Abattis Bioceuticals Corp. is a specialty biotechnology company with capabilities through its wholly owned subsidiaries of producing, licensing and marketing proprietary ingredients and products containing standardized phytochemicals for sale in Pharmaceutical, Nutraceutical, Cosmetic and Animal Nutrition markets. The company also has a deep pipeline of proprietary products ready for sale in high growth areas of Functional Foods and Supplements business. For more information, visit the Company's website at www.abattis.com.

About Crudessence and Rise Kombucha.

RISE is a young rapidly growing company committed to offering living, sparkling tea beverages. In harmony with nature, our kombucha not only tastes good but also is the perfect adjunct to good health. RISE is a brand that is in sync with the evolution of society. By combining the best in natural health and the best scientific research available, we offer a delicious, healthy and affordable whole food beverage.

ON BEHALF OF THE BOARD

" Michael Withrow "                                                                        
Michael Withrow , President & CEO

Neither the CNSX Exchange nor its regulations services accepts responsibility for the adequacy or accuracy of this release.

 

Contact: Nick Brusatore , +1-604-356-0411, nbrusatore@gmail.com


'/>"/>
SOURCE Abattis Bioceuticals Corp.
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Life Technologies Signs License and Collaborative Stem Cell Research Agreement with Harvard University
2. Palomar Medical Center in San Diego County Introduces New Wrist-Worn Wireless Patient Vital Signs Device
3. Aviir Signs Distribution And Expansion Pact Covering 19 Middle Eastern And North African Countries
4. Aviir Signs Distribution and Expansion Pact Covering 19 Middle Eastern and North African Countries
5. Infinata’s BioPharm Insight Signs 200th Media Partner, Inaugurates Advertising Program
6. AMRI Signs Agreement for Exclusive License of its Tubulin Inhibitor Program for Cancer
7. Deborah Morosini, MD Pathologist and Patient Advocate Signs on as Medical Director and Advisory Board Member of Store-A-Tooth™ Dental Stem Cell Banking
8. Trade Show Display Co. GLM Displays Redesigns Blog
9. Touch Medical Media Splits From Touch Briefings, Launches a Series of Cutting Edge, Free to Access, Educational Resources and Signs an Updated Media Partnership With ECCO, The European CanCer Organisation Representing 60,000 Oncology Professionals
10. MakeSigns.com Announces New Tri-Fold Scientific Poster Service
11. Florida-Based Team Gemini Signs Recycling Facility Agreement with Solid Waste Authority of Central Ohio
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2017)... ... May 23, 2017 , ... ... month its 20th anniversary, marking the occasion with a strong presence at Bio-IT ... Welcome Reception and further extends an invitation to all attendees to view ...
(Date:5/23/2017)... ... , ... Vortex Biosciences , provider of circulating tumor cell (CTC) capture ... using Vortex microfluidic technology ” in Nature Precision Oncology on May 8th. The ... and Dr. Matthew Rettig at the University of California, Los Angeles. The publication describes ...
(Date:5/23/2017)... ... ... Bacterial biofilms, surface adherent communities of bacteria that are encased in a ... and catheter infections to gum disease and the rejection of medical implants. Though ... year, there is currently a paucity of means for preventing their formation or treating ...
(Date:5/22/2017)... ... May 22, 2017 , ... Stratevi, a boutique firm that partners ... Coast. It has opened an office in downtown Boston at 745 Atlantic Ave. ... more important to generate evidence on the value they provide, not just to patients, ...
Breaking Biology Technology:
(Date:4/4/2017)...   EyeLock LLC , a leader of iris-based ... Patent and Trademark Office (USPTO) has issued U.S. Patent ... an iris image with a face image acquired in ... 45 th issued patent. "The ... the multi-modal biometric capabilities that have recently come to ...
(Date:3/30/2017)... KONG , March 30, 2017 The ... a system for three-dimensional (3D) fingerprint identification by adopting ground breaking ... into a new realm of speed and accuracy for use in ... at an affordable cost. ... ...
(Date:3/28/2017)... , March 28, 2017 The ... Hardware (Camera, Monitors, Servers, Storage Devices), Software (Video Analytics, ... Region - Global Forecast to 2022", published by MarketsandMarkets, ... 2016 and is projected to reach USD 75.64 Billion ... and 2022. The base year considered for the study ...
Breaking Biology News(10 mins):